Home · Healthcare · LLY
Daniel M. Skovronsky M.D. Ph.D.
Executive Officer · Eli Lilly (LLY)
FY2025 Compensation
Total Compensation FY2025
$887,845
As reported in 2026 DEF 14A proxy filing with the SEC
Compensation Breakdown
Base Salary
$1.5M
168% of total
Stock Awards
—
0% of total
Bonus
—
0% of total
Other Compensation
—
0% of total
Compensation History
Total compensation by fiscal year, as reported in SEC proxy filings.
Data Source: Compensation figures are sourced from Eli Lilly's DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect total compensation for FY2025 as reported in the Summary Compensation Table.